Home › Agent Hub › Agent Tools › Part D coverage by drug › Desloratadine
Agent Tools
Desloratadine is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,382 of 5,492 Medicare Part D and Medicare Advantage drug plans (79.8%) list Desloratadine on their formulary, across 141 of 286 formularies. The most common placement is tier 3 (2,407 plans, 54.9% of those covering it). 0 of the covering plans require prior authorization (0%), 54 step therapy and 2,607 a quantity limit.
1,825 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 1,114 of them $0; 2,557 charge coinsurance instead — median 21% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,143 of 5,496 plans covered it (75.4%); 2027: 4,382 of 5,492 (79.8%).
Of 4,367 plans offered in both years, 301 added it to the formulary and 18 dropped it.
Among plans covering it both years, 47 moved it to a higher tier and 279 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 415 |
| Tier 2 | 1,513 |
| Tier 3 | 2,407 |
| Tier 4 | 47 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 238 of 323 | 73.7% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,553 of 3,200 | 79.8% | 0% |
| Special needs plans (SNP) | 1,591 of 1,969 | 80.8% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 3 | 0 |
| UnitedHealthcare | 796 of 830 | Tier 3 | 0 |
| Devoted Health | 446 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 2 | 0 |
| Wellcare | 234 of 268 | Tier 1 | 0 |
| HealthSpring | 226 of 226 | Tier 2 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 2 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 1 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 2 | 0 |
| Anthem Blue Cross and Blue Shield | 69 of 74 | Tier 2 | 0 |
| Wellpoint | 50 of 63 | Tier 2 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 4 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 3 | 0 |
| Zing Health | 6 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 8 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 25 of 26 | Tier 2 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 2 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 102 of 114 | 89.5% |
| Alaska | 7 of 9 | 77.8% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 103 of 147 | 70.1% |
| Arkansas | 72 of 85 | 84.7% |
| California | 258 of 397 | 65% |
| Colorado | 83 of 106 | 78.3% |
| Connecticut | 44 of 54 | 81.5% |
| Delaware | 34 of 43 | 79.1% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 438 of 545 | 80.4% |
| Georgia | 129 of 149 | 86.6% |
| Guam | 1 of 1 | 100% |
| Hawaii | 28 of 50 | 56% |
| Idaho | 34 of 45 | 75.6% |
| Illinois | 101 of 132 | 76.5% |
| Indiana | 108 of 138 | 78.3% |
| Iowa | 51 of 64 | 79.7% |
| Kansas | 73 of 84 | 86.9% |
| Kentucky | 111 of 121 | 91.7% |
| Louisiana | 101 of 125 | 80.8% |
| Maine | 48 of 52 | 92.3% |
| Maryland | 26 of 49 | 53.1% |
| Massachusetts | 58 of 89 | 65.2% |
| Michigan | 160 of 182 | 87.9% |
| Minnesota | 36 of 63 | 57.1% |
| Mississippi | 92 of 104 | 88.5% |
| Missouri | 140 of 170 | 82.4% |
| Montana | 23 of 27 | 85.2% |
| Nebraska | 37 of 51 | 72.5% |
| Nevada | 74 of 100 | 74% |
| New Hampshire | 20 of 25 | 80% |
| New Jersey | 60 of 73 | 82.2% |
| New Mexico | 57 of 68 | 83.8% |
| New York | 172 of 215 | 80% |
| North Carolina | 134 of 176 | 76.1% |
| North Dakota | 14 of 26 | 53.8% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 128 of 171 | 74.9% |
| Oklahoma | 67 of 81 | 82.7% |
| Oregon | 57 of 92 | 62% |
| Pennsylvania | 269 of 323 | 83.3% |
| Puerto Rico | 64 of 64 | 100% |
| Rhode Island | 23 of 29 | 79.3% |
| South Carolina | 75 of 89 | 84.3% |
| South Dakota | 16 of 30 | 53.3% |
| Tennessee | 134 of 156 | 85.9% |
| Texas | 360 of 407 | 88.5% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 48 of 53 | 90.6% |
| Vermont | 10 of 14 | 71.4% |
| Virginia | 123 of 144 | 85.4% |
| Washington | 85 of 114 | 74.6% |
| West Virginia | 62 of 69 | 89.9% |
| Wisconsin | 76 of 96 | 79.2% |
| Wyoming | 11 of 13 | 84.6% |
Medicare Part D paid for 314,576 30-day fills of Desloratadine in 2024 for about 49,339 enrollees, at an average total cost of $21.58 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Desloratadine and the rest of a client's list on every plan in their county.
Estimate Desloratadine costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.